Patient Advocate Foundation: Sancuso

Patient access and
assistance programs

Resources
EZ Access Specialty
Pharmacy Program
ProStraCARE™
Cover My Meds

> Patient Advocate Foundation

SANCUSO can be worn
for 7 days.

About

The Patient Advocate Foundation provides effective mediation and arbitration services to patients
so that obstacles to obtaining health care can be overcome.

Copay relief program (CRP)

Provides direct financial support to insured patients, including Medicare Part D beneficiaries,
who are being treated for a wide range of cancers
Patients must be financially and medically qualified
Offers personal service to all patients through the use of call counselors
For more information, call 1-800-532-5274 or visit www.patientadvocate.org
Supported by a grant from ProStrakan, Inc.

IMPORTANT SAFETY INFORMATION
SANCUSO^® (Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.¹ SANCUSO is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the patch.¹ Granisetron may mask a progressive ileus and/or gastric distention caused by the underlying condition.¹ Mild application site reactions have occurred; remove the patch if severe reaction or a generalized skin reaction occurs.¹ Patients should avoid direct exposure of application site to natural or artificial sunlight by covering with clothing while wearing the patch and for 10 days after removing it.¹ The most common adverse reaction in patients receiving SANCUSO is constipation (5.4%).¹ SANCUSO contains granisetron.¹ Healthcare professionals should avoid prescribing any additional products that contain granisetron. No clinically relevant drug interactions have been reported in clinical studies with SANCUSO.¹